115 related articles for article (PubMed ID: 14652282)
1. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Lichtenegger W
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1205-8. PubMed ID: 14652282
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.
Mustea A; Sehouli J; Könsgen D; Stengel D; Sofroni D; Lichtenegger W
Anticancer Res; 2003; 23(2A):1099-102. PubMed ID: 12820354
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.
Hefler LA; Ludwig E; Lebrecht A; Zeillinger R; Tong-Cacsire D; Koelbl H; Leodolter S; Tempfer CB
J Soc Gynecol Investig; 2002; 9(6):386-90. PubMed ID: 12445604
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer.
Zhang Z; Zhou B; Zhang J; Chen Y; Lai T; Yan L; Liang A; Li Y; Wang Y; Chen Y; Zhang L; Xi MR
Cancer Genet Cytogenet; 2010 Jan; 196(2):146-52. PubMed ID: 20082850
[TBL] [Abstract][Full Text] [Related]
5. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
Bid HK; Manchanda PK; Mittal RD
Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Chen FC; Lichtenegger W
Ann Oncol; 2003 Oct; 14(10):1501-4. PubMed ID: 14504049
[TBL] [Abstract][Full Text] [Related]
7. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease.
Manzoli A; Andreotti F; Varlotta C; Mollichelli N; Verde M; van de Greef W; Sperti G; Maseri A
Cardiologia; 1999 Sep; 44(9):825-30. PubMed ID: 10609392
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis.
Grimm C; Berger I; Tomovski C; Zeillinger R; Concin N; Leodolter S; Koelbl H; Tempfer CB; Hefler LA
Gynecol Oncol; 2004 Mar; 92(3):936-40. PubMed ID: 14984963
[TBL] [Abstract][Full Text] [Related]
9. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
[TBL] [Abstract][Full Text] [Related]
11. The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population.
Starzyńska T; Ferenc K; Wex T; Kähne T; Lubiński J; Lawniczak M; Marlicz K; Malfertheiner P
Am J Gastroenterol; 2006 Feb; 101(2):248-54. PubMed ID: 16454826
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A
Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
Viet HT; Wågsäter D; Hugander A; Dimberg J
Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
[TBL] [Abstract][Full Text] [Related]
14. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
15. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.
Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H
Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127
[TBL] [Abstract][Full Text] [Related]
16. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ
Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608
[TBL] [Abstract][Full Text] [Related]
18. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer.
Glas J; Török HP; Schneider A; Brünnler G; Kopp R; Albert ED; Stolte M; Folwaczny C
J Clin Oncol; 2004 Dec; 22(23):4746-52. PubMed ID: 15570075
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
